Published on in Vol 4, No 9 (2020): September
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/17126, first published
.
Journals
- Cignarella A, Mioni R, Sabbadin C, Dassie F, Parolin M, Vettor R, Barbot M, Scaroni C. Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS. International Journal of Molecular Sciences 2020;21(24):9554 View
- Liu Z, Song Y, Xu Y, Wang J, Hu H, Weng Y. The comparison of the effectiveness and safety of drospirone ethinyl estradiol and ethinyl estradiol cyproterone in the treatment of polycystic ovarian syndrome. Medicine 2020;99(51):e23811 View
- Choi H, Lee S, Yang S. Development of an integrated mobile application for lifestyle modification in women with polycystic ovarian syndrome. Journal of Clinical Nursing 2023;32(1-2):49 View
- H. Al Wattar B, M. Hussain N, S. Khan K. Lifestyle interventions in women with polycystic ovary syndrome: A scoping systematic review of randomised evidence. Medicina de Familia. SEMERGEN 2022;48(3):186 View
- McGowan M, Garad R, Wadhwani G, Torkel S, Rao V, Maunder A, Osei‐Safo E, Moran L, Cowan S. Understanding barriers and facilitators to lifestyle management in people with polycystic ovary syndrome: A mixed method systematic review. Obesity Reviews 2024 View
- Krishnan N, B S, AJ H. Evaluation of Sleep Disturbances in Women with Polycystic Ovary Syndrome. International Journal of Infertility & Fetal Medicine 2024;15(2):83 View